A citation-based method for searching scientific literature

Renato Budzyn David, Eduardo Dytz Almeida, Larissa Vargas Cruz, Juliana Cañedo Sebben, Ivan Petry Feijó, Karine Elisa Schwarzer Schmidt, Luísa Martins Avena, Carlos Antonio Mascia Gottschall, Alexandre Schaan de Quadros. Arq Bras Cardiol 2014
Times Cited: 7







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
Mikhail Kosiborod, Saif S Rathore, Silvio E Inzucchi, Frederick A Masoudi, Yongfei Wang, Edward P Havranek, Harlan M Krumholz. Circulation 2005
433
42


Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction.
Maarten de Mulder, Tjeerd van der Ploeg, Guus A de Waard, Eric Boersma, Victor A Umans. Cardiology 2011
7
28

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.
Kim A Eagle, Michael J Lim, Omar H Dabbous, Karen S Pieper, Robert J Goldberg, Frans Van de Werf, Shaun G Goodman, Christopher B Granger, P Gabriel Steg, Joel M Gore,[...]. JAMA 2004
28


Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock.
Jeong Hoon Yang, Pil Sang Song, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee, Myung-Ho Jeong, Young-Jo Kim, Hyeon-Cheol Gwon. Crit Care 2013
27
28

Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome.
Roberto R Giraldez, Robert M Clare, Renato D Lopes, Anthony J Dalby, Dorairaj Prabhakaran, Gerard X Brogan, Robert P Giugliano, Stefan K James, Jean-Francois Tanguay, Charles V Pollack,[...]. Am Heart J 2013
52
28


The prognostic role of in-hospital peak glycemia in stemi patients with and without diabetes.
Chiara Lazzeri, Serafina Valente, Marco Chiostri, Paola Attanà, Claudio Picariello, Gian Franco Gensini. Acta Diabetol 2012
12
28

Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study.
Gianni Casella, Stefano Savonitto, Francesco Chiarella, Lucio Gonzini, Antonio Di Chiara, Leonardo Bolognese, Stefano De Servi, Cesare Greco, Pietro Zonzin, Stefano Coccolini,[...]. Ital Heart J 2005
19
28


Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study.
Anish George, Raghav T Bhatia, Gill L Buchanan, Anne Whiteside, Robert S Moisey, Stephen F Beer, Sudipta Chattopadhyay, Thozhukat Sathyapalan, Joseph John. PLoS One 2015
35
28

Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Donghun Shin, Jinhee Ahn, Kwang Soo Cha, Jin Sup Park, Jun-Hyok Oh, Hye-Won Lee, Ju-Yong Hong, Bo-Won Kim, Taek Jong Hong. Coron Artery Dis 2016
15
28

Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
Filipe A Moura, Valeria N Figueiredo, Bruna S B S Teles, Meyrianne A Barbosa, Lara R Pereira, Ana P R Costa, Luiz Sergio F Carvalho, Riobaldo M R Cintra, Osório L R Almeida, Jose C Quinaglia E Silva,[...]. Atherosclerosis 2015
14
28

Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
Jorik R Timmer, Miriam Hoekstra, Maarten W N Nijsten, Iwan C C van der Horst, Jan Paul Ottervanger, Robbert J Slingerland, Jan-Henk E Dambrink, Henk J G Bilo, Felix Zijlstra, Arnoud W J van 't Hof. Circulation 2011
155
28

Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities.
Jacek Kowalczyk, Michal Mazurek, Teresa Zielinska, Radoslaw Lenarczyk, Agnieszka Sedkowska, Andrzej Swiatkowski, Beata Sredniawa, Grzegorz Mencel, Pawel Francuz, Zbigniew Kalarus. Eur J Prev Cardiol 2015
20
28

Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes.
R Gao, A Patel, W Gao, D Hu, D Huang, L Kong, W Qi, Y Wu, Y Yang, P Harris,[...]. Heart 2008
73
14

Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients.
A Tenerz, G Nilsson, R Forberg, J Ohrvik, K Malmberg, C Berne, J Leppert. J Intern Med 2003
43
14


Predictive impact on medium-term mortality of hematological parameters in Acute Coronary Syndromes: added value on top of GRACE risk score.
Ana T Timóteo, Ana L Papoila, Ana Lousinha, Marta Alves, Fernando Miranda, Maria L Ferreira, Rui C Ferreira. Eur Heart J Acute Cardiovasc Care 2015
17
14

Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction.
Ida Gustafsson, Caroline N Kistorp, Margaret K James, Jens O Faber, Kenneth Dickstein, Per R Hildebrandt. Am Heart J 2007
43
14

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.
Michael J Pencina, Ralph B D'Agostino, Ewout W Steyerberg. Stat Med 2011
14

Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
Christian Widera, Michael J Pencina, Allison Meisner, Tibor Kempf, Kerstin Bethmann, Ivonne Marquardt, Hugo A Katus, Evangelos Giannitsis, Kai C Wollert. Eur Heart J 2012
63
14


Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
14


Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE).
Keith A A Fox, Omar H Dabbous, Robert J Goldberg, Karen S Pieper, Kim A Eagle, Frans Van de Werf, Alvaro Avezum, Shaun G Goodman, Marcus D Flather, Frederick A Anderson,[...]. BMJ 2006
868
14

Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome.
Barbara Elisabeth Stähli, Keiko Yonekawa, Lukas Andreas Altwegg, Christophe Wyss, Danielle Hof, Philipp Fischbacher, Andreas Brauchlin, Georg Schulthess, Pierre-Alexandre Krayenbühl, Arnold von Eckardstein,[...]. PLoS One 2014
9
14

C-reactive protein improves risk prediction in patients with acute coronary syndromes.
François Schiele, Nicolas Meneveau, Marie France Seronde, Romain Chopard, Vincent Descotes-Genon, Joanna Dutheil, Jean-Pierre Bassand. Eur Heart J 2010
42
14

Comparison of baseline characteristics and one-year outcomes between African-Americans and Caucasians undergoing percutaneous coronary intervention.
Laurent Leborgne, Edouard Cheneau, Roswitha Wolfram, Ellen E Pinnow, Daniel A Canos, Augusto D Pichard, William O Suddath, Lowell F Satler, Joseph Lindsay, Ron Waksman. Am J Cardiol 2004
18
14

Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization.
Roberto A Corpus, William W O'Neill, Simon R Dixon, Gerald C Timmis, William H Devlin. Am J Cardiol 2003
59
14


Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
Jorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, Eric Boersma, Cindy L Grines, Cynthia M Westerhout, R John Simes, Christopher B Granger, Felix Zijlstra. Arch Intern Med 2007
54
14

Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
Giuseppe Penno, Anna Solini, Giacomo Zoppini, Emanuela Orsi, Cecilia Fondelli, Gianpaolo Zerbini, Susanna Morano, Franco Cavalot, Olga Lamacchia, Roberto Trevisan,[...]. Cardiovasc Diabetol 2013
47
14

Percutaneous coronary intervention in Asians--are there differences in clinical outcome?
Angela S Koh, Lay W Khin, Lok M Choi, Ling L Sim, Terrance S Chua, Tian H Koh, Jack W Tan, Stanley Chia. BMC Cardiovasc Disord 2011
10
14

Combination of mean platelet volume and the GRACE risk score better predicts future cardiovascular events in patients with acute coronary syndrome.
Zhao-Fei Wan, Dong Zhou, Jia-Hong Xue, Yan Wu, Huan Wang, Yan Zhao, Ling Zhu, Zu-Yi Yuan. Platelets 2014
22
14

Ethnic differences in acute myocardial infarction in Singapore.
K-H Mak, K-S Chia, J D Kark, T Chua, C Tan, B-H Foong, Y-L Lim, S-K Chew. Eur Heart J 2003
106
14



2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Jeffrey L Anderson, Cynthia D Adams, Elliott M Antman, Charles R Bridges, Robert M Califf, Donald E Casey, William E Chavey, Francis M Fesmire, Judith S Hochman, Thomas N Levin,[...]. Circulation 2013
183
14



Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.
Bowen Lin, Nobutaka Koibuchi, Yu Hasegawa, Daisuke Sueta, Kensuke Toyama, Ken Uekawa, MingJie Ma, Takashi Nakagawa, Hiroaki Kusaka, Shokei Kim-Mitsuyama. Cardiovasc Diabetol 2014
188
14

Absolute change in fasting plasma glucose over 12 months is associated with 2-year and 5-year major adverse cardiovascular events in patients with drug-eluting stent implants.
Dong Oh Kang, Hong Seog Seo, Byung Geol Choi, Eunmi Lee, Ji Park Kim, Sun Ki Lee, Sung Il Im, Jin Oh Na, Cheol Ung Choi, Hong Euy Lim,[...]. Int J Cardiol 2015
6
16

The relationship between acute coronary syndrome and stress hyperglycemia.
H Ayhan, T Durmaz, T Keleş, N A Bayram, E Bilen, M Akçay, R Ersoy, E Bozkurt. Exp Clin Endocrinol Diabetes 2014
8
14

Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores.
Krishna G Aragam, Umesh U Tamhane, Eva Kline-Rogers, Jin Li, Keith A A Fox, Shaun G Goodman, Kim A Eagle, Hitinder S Gurm. PLoS One 2009
85
14

Comparison of five-year outcome in African Americans versus Caucasians following percutaneous coronary intervention.
Jyotiranjan Pradhan, Theodore L Schreiber, Ashutosh Niraj, Vikas Veeranna, Krithi Ramesh, Lisa Saigh, Luis Afonso. Catheter Cardiovasc Interv 2008
17
14

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study.
Ya-Ling Han, Lei Zhang, Li-Xia Yang, Hui-Liang Liu, Peng Qu, Wei-Min Li, Tie-Min Jiang, Shu-Mei Li, Quan-Min Jing, Quan-Yu Zhang,[...]. EuroIntervention 2012
27
14


Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction.
William S Harris, Kevin F Kennedy, James H O'Keefe, John A Spertus. Int J Cardiol 2013
39
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.